Marc Bonten
banner
marcbonten.bsky.social
Marc Bonten
@marcbonten.bsky.social
Professor of Molecular Epidemiology of Infectious Diseases @UMCUtrecht. CEO of the European Clinical Research Alliance on Infectious Diseases, @ecraid. All opinions my own.
We actually discovered over-the-counter selling of antibiotics
@cmicomms.bsky.social
September 11, 2025 at 5:03 PM
Now on stage #ESCMIDGlobal2025 dr Cristina Prat presenting data from the ongoing PNEUMO study that aims to quantify the seroprevalence of pneumococcal pneumonia and invasive disease. @ecraid.bsky.social @umcutrecht.bsky.social
April 13, 2025 at 10:38 AM
Nice to see the results from the @ecraid.bsky.social POS-cUTI presented by Chantal Kats, treatment duration of complicated UTI is very heterogeneous and some baseline characteristics are prognostic for durations of >14 days. Results from 1st 1000 patients, currently >3000 in the study.
April 13, 2025 at 9:27 AM
Excellent presentation by Vitoria Colizza on the role of school closures during the pandemic at @escmid.bsky.social Global2025. For the Netherlands: 5 yrs after the fact I am less convinced that closing schools during the first wave was a stupid thing to do.
April 12, 2025 at 12:34 PM
I’m in Austria
April 11, 2025 at 12:22 PM
Today & tomorrow we're meeting in Cascais for the @ecraid.bsky.social Foundation Science Meeting and the General Assembly meetings of the @ec.europa.eu funded projects ECRAID-BASE and ECRAID-PRIME. If the wind is fierce and cold, scientific collaboration must be strengthened. @escmid.bsky.social
March 10, 2025 at 10:42 AM
On the origin of the MMR autism myth. Published in 2020, on page 354: "If 10.000 people say the same thing (autism bc of MMR) - the 10.000 mothers - anecdotes ultimately become science," was how the lawyer Robert Kennedy presented the argument at an anti-vaccine rally in Atlanta.
👇
February 27, 2025 at 7:11 AM
Preparing my talk for the AMR Conference next week in Basel. Clinical endpoints for hospital/ventilator-associated pneumonia: all-cause mortality or clinical cure? Or something else, including both? Ecraid study: 30 ICU's, countries, almost 5K patients at risk for VAP, 17% developing VAP.
February 17, 2025 at 8:00 AM
Vandaag een andere start dan gebruikelijk (onderzoeksoverleg). Behandeling zaak waarin @umcutrecht.bsky.social verantwoordelijk gesteld wordt voor oplopen COVID-19 infectie van medewerker (die vervolgens Long-COVID kreeg).
January 8, 2025 at 7:36 AM
Zit klaar. Nu op NPO1 Spraakmakers, omdat ongeveer precies 5 jaar geleden de eerste mens COVID-19 moet hebben gehad @umcutrecht.bsky.social
November 22, 2024 at 8:32 AM
Opmerkelijk bericht....
November 21, 2024 at 8:21 AM
2-day meeting to align our actions for a coordinated research approach in Europe in case of a new infectious disease threat. View from the meeting room 👇
Where is the meeting?
@ec.europa.eu
November 14, 2024 at 10:13 AM
2nd day of our annual meeting of PriMAVeRa; an IHI project in which the potential effects of vaccines and monoclonal antibodies on antimicrobial resistance is investigated using literature studies and mathematical modeling. See www.primavera/amr.eu
November 8, 2024 at 8:03 AM
🙏🏾 to all lecturers & participants who joined the Ecraid x ESCMID 'Better Methods' postgrad course in Belgrade! The past three days of knowledge exchange were intense but so rewarding.
👉🏼 Discover more training opportunities and existing resources at ecraid.eu/education
media.licdn.com/dms/image/v2...
October 24, 2024 at 12:24 PM
Better methods for clinical studies in infectious diseases & clinical microbiology!

3-day post-graduate course from ESCMID and Ecraid started this morning in Belgrade with course attendants, mostly young investigators, from multiple countries.

On stage Aleksandra Barac
October 22, 2024 at 10:37 AM
Not just another day at the office.
October 16, 2024 at 11:02 AM